Xianwu Hua
Overview
Explore the profile of Xianwu Hua including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
42
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li X, Wang H, Lai W, Liao J, Mo W, Huang K, et al.
Immunology
. 2024 Mar;
172(3):375-391.
PMID: 38471664
Persistent human papillomavirus (HPV) infection is associated with multiple malignancies. Developing therapeutic vaccines to eliminate HPV-infected and malignant cells holds significant value. In this study, we introduced a lipid nanoparticle...
2.
Hou F, Zhang Y, Liu X, Murad Y, Xu J, Yu Z, et al.
Nat Commun
. 2023 Sep;
14(1):5925.
PMID: 37739969
The recent outbreaks of mpox have raised concerns over the need for effective vaccines. However, the current approved vaccines have either been associated with safety concerns or are in limited...
3.
Lu C, Zhang Y, Liu X, Hou F, Cai R, Yu Z, et al.
Antiviral Res
. 2023 Mar;
212:105556.
PMID: 36871919
The coronavirus SARS-CoV-2 has mutated quickly and caused significant global damage. This study characterizes two mRNA vaccines ZSVG-02 (Delta) and ZSVG-02-O (Omicron BA.1), and associating heterologous prime-boost strategy following the...
4.
Fu L, Hua X, Jiang X, Shi J
Nano Lett
. 2021 Dec;
22(1):111-118.
PMID: 34962818
Current clinical applications of protein therapy are largely limited to systemically accessible targets in vascular or extracellular areas. Major obstacles to the widespread application of protein therapeutics in cancer treatment...
5.
Huang X, Wu G, Liu C, Hua X, Tang Z, Xiao Y, et al.
Nano Lett
. 2021 Nov;
21(22):9706-9714.
PMID: 34723546
RNA interference (RNAi) is a powerful approach in the treatment of various diseases including cancers. The clinical translation of small interfering RNA (siRNA)-based therapy requires safe and efficient delivery vehicles....